Nina Capital is a specialized venture capital firm investing exclusively at the intersection of healthcare and technology. The firm funds early-stage companies, from pre-seed to seed+ rounds, across a pan-European and global footprint including the United States, Israel, Canada, and Australia. It emphasizes need-driven founders and data/compute-powered health tech, with ticket sizes from 200k€ to 1500k€ and the ability to lead rounds or coinvest. Notably, the firm avoids drugs and vaccines, focusing on transformative health tech solutions.